ReviewCurrent oncology (Toronto, Ont.)2023

The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.

Ugo Testa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.